Latest news and press releases about GoodRx Holdings, Inc. (GDRX): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States.
Price
| Price | $3.36 |
| Market Cap | $1.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 77.18 |
| Price / Book | 1.72 |
| EV / EBITDA | 9.29 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 2.61% |
| Return on Invested Capital | 2.64% |
| Return on Assets | 0.69% |
| Gross Margin | 88.05% |
| Operating Margin | 10.25% |
| Net Margin | 2.07% |
Related companies: AHCO · AMPH · COLL · CTEV · HSTM · INVA · IRMD
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of GDRX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks